02013oam 2200541 450 991071547110332120210412074756.038-120(CKB)5470000002511331(OCoLC)1243270141(EXLCZ)99547000000251133120210325d2021 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierLowering the cost of prescription drugs reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019Washington :U.S. Government Publishing Office,2021.1 online resource (vi, 246 pages)Access ID (govinfo): CHRG-116hhrg38120."Serial no. 116-17."Includes bibliographical references.Lowering the cost of prescription drugs Prescription pricingUnited StatesPublic opinionDrugsGeneric substitutionLaw and legislationUnited StatesDrugsLaw and legislationUnited StatesDrugsUnited StatesPatentsPatent laws and legislationUnited StatesCompetitionUnited StatesPharmaceutical industryUnited StatesLegislative hearings.lcgftPrescription pricingPublic opinion.DrugsGeneric substitutionLaw and legislationDrugsLaw and legislationDrugsPatents.Patent laws and legislationCompetitionPharmaceutical industryGPOGPOGPOOCLCOGPOBOOK9910715471103321Lowering the cost of prescription drugs3449428UNINA